Korea's LOTTE buys Bristol Myers Squibb's US facility for expanding CDMO biz
Korea | News | 0 Comment | 16 May, 2022
South Korean firm LOTTE has agreed to purchase Bristol Myers Squibb’s manufacturing facility in East Syracuse, New...Read more
GenScript ProBio builds up presence in APAC
Korea | News | 0 Comment | 13 May, 2022
GenScript ProBio, a global CDMO company from GenScript Biotech Corporation, has announced the opening of a legal entity ...Read more
Korea to open new chapter in world's antiviral drug history
Korea | News | 0 Comment | 12 May, 2022
The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antivir...Read more
UK inks agreement with Korea for disease control and prevention
Korea | News | 0 Comment | 09 May, 2022
Dr Dame Jenny Harries, Chief Executive of the UK Health Security Agency (UKHSA), has signed a Memorandum of Understandin...Read more
Korea builds deep learning model to predict adverse drug-drug interactions
Korea | News | 0 Comment | 06 May, 2022
The intake of multiple drugs can result in adverse health effects due to unexpected drug-drug interactions (DDIs). Now, ...Read more
Korea develops wireless brain neurochemical system to study Parkinson’s disease
Korea | News | 0 Comment | 04 May, 2022
A group of researchers at Korea University have developed an electronic medical system that can be inserted into de...Read more
SK bioscience reaches final stage of developing Korea´s first COVID-19 vaccine
Korea | News | 0 Comment | 02 May, 2022
South Korea-based SK bioscience and GSK have announced submission of a biologics license application for SKYCovione a re...Read more
South Korean firms lay focus on immune cell therapy
Korea | News | 0 Comment | 29 Apr, 2022
Daewoong Pharmaceutical has signed a joint research and development agreement with UCI Therapeutics (CEO Sooyoung Jung),...Read more
Korean firm GC Biopharma explores use of lipid nanoparticle delivery system in mRNA vaccines
Korea | News | 0 Comment | 28 Apr, 2022
GC Biopharma, based in South Korea, and Canadian firm Acuitas Therapeutics, a company focused on developing lipid nanopa...Read more
Korea | News | 0 Comment | 27 Apr, 2022
Korea's PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next-generation antibody thera...Read more
Korea's Seegene unveils world's first commercialised '3 Ct' PCR assay
Korea | News | 0 Comment | 27 Apr, 2022
Seegene Inc., South Korea's leading molecular diagnostics (MDx) company, has announced the development of the ...Read more
Adge Pharma, Cyan Bio advance treatments for rare paediatric diseases in Asian countries
Korea | News | 0 Comment | 26 Apr, 2022
Adge Pharmaceuticals has entered into a license agreement with South Korea-based Cyan Bio, Inc. Cyan will receive exclus...Read more
Korean firm Vuno partners with Mayo Clinic for AI-based precision oncology
Korea | News | 0 Comment | 25 Apr, 2022
South Korea-based startup Vuno has signed a research agreement with Mayo Clinic in the US. The research agreement, which...Read more
Korea develops COVID-19 detection platform by 'slowing down light'
Korea | News | 0 Comment | 22 Apr, 2022
A research group led by Professor Young Min Song of the Gwangju Institute of Science and Technology in Korea h...Read more
Korea's LG Chem pushes targeting of global atopic dermatitis market worth KRW 29 trillion
Korea | News | 0 Comment | 21 Apr, 2022
South Korea's LG Chem has announced that its Chinese counterpart TransThera Sciences received the IND clearance fro...Read more
Korean firm GC buys US-based CDMO BioCentriq to enhance global capabilities
Korea | News | 0 Comment | 20 Apr, 2022
GC corp., the holding (system) company for GC group in South Korea with major operating companies across healthcare se...Read more
GeneQuantum and AIMEDBIO collaborate on a first-in-class antibody drug conjugate
Korea | News | 0 Comment | 19 Apr, 2022
China's GeneQuantum Healthcare, a company specializing in site-specific bioconjugation for next generation biotherapeuti...Read more
Korea's Bridge Biotherapeutics to enhance solutions for idiopathic pulmonary fibrosis
Korea | News | 0 Comment | 19 Apr, 2022
Bridge Biotherapeutics, a South Korean clinical-stage biotechnology company focused on developing novel drugs for fibros...Read more